Teriparatide 560MCG/2.24ML pen 2.24ML
Ended Awarded
- Contract number
- SPE2DR26FCN3C
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $13,548
Award facts
- Contract value 100% obligated
- $13,547.78 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $13,547.78 to AmerisourceBergen Drug Corp for the supply of Teriparatide 560mcg/2.24ml pen injections. This is a firm fixed price delivery order with an ultimate completion date of November 10, 2025, and represents a non-set-aside competitive award. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.999 billion comprehensive global pharmaceutical support vehicle running through December 2026 that enables the company to supply a broad range of medications and medical supplies to military healthcare programs worldwide.
Teriparatide is a bone-building medication commonly used in the treatment of osteoporosis, particularly in patients at high risk of fractures. AmerisourceBergen, as a major pharmaceutical distributor and critical federal medical procurement vendor, routinely fulfills such pharmaceutical orders through its expansive IDC with DLA, which covers specialty medications, brand-name and generic drugs, vaccines, and related medical supplies across multiple therapeutic domains. The company's federal contract portfolio demonstrates consistent capability to meet competitive procurement requirements across the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems.
Quick answers
Who was awarded contract SPE2DR26FCN3C?
SPE2DR26FCN3C was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 7, 2025.
How much is contract SPE2DR26FCN3C worth?
The government has obligated $13,548 on SPE2DR26FCN3C.
Is contract SPE2DR26FCN3C an order under another contract?
Yes. SPE2DR26FCN3C is a delivery order under SPE2DR25D1100, an indefinite delivery contract.
Was contract SPE2DR26FCN3C competed?
The extent of competition for SPE2DR26FCN3C was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award